Acorda Therapeutics, Inc. ACOR
0.66 +0.66
Day range unavailable
52-week range unavailable
Revenue & Expenses
Latest period ending Dec 31, 2023 · select a line to chart its full history
Income statement
| Fiscal year | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 |
|---|---|---|---|---|---|
| 117.63M | 118.57M | 129.07M | 152.97M | 192.41M | |
| 102.35M | 88.23M | 88.28M | 119.45M | 157.56M | |
| -274.59M | -42.04M | -77.30M | -148.92M | -398.57M | |
| -252.85M | -65.92M | -103.95M | -99.59M | -272.97M | |
| -203.57 | -65.23 | -195.80 | -246.40 | -688.60 |
Balance sheet
| Fiscal year | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 |
|---|---|---|---|---|---|
| 30.61M | 44.67M | 65.22M | 102.89M | 105.19M | |
| 108.53M | 395.60M | 455.47M | 632.68M | 799.72M | |
| 266.48M | 301.97M | 304.33M | 394.73M | 488.90M | |
| 190.90M | 172.92M | 190.94M | 259.95M | 249.61M | |
| -157.96M | 93.62M | 151.14M | 237.96M | 310.82M |
Cash flow
| Fiscal year | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 |
|---|---|---|---|---|---|
| -13.98M | -20.92M | -41.35M | -61.01M | -128.17M | |
| -264.00K | -136.00K | 73.78M | 59.36M | -505.00K | |
| -264.00K | -136.00K | -165.00K | -4.39M | -90.43M | |
| -14.06M | -20.55M | -37.67M | -2.30M | -189.16M |